[go: up one dir, main page]

WO2006018807A8 - Crystalline forms of cefdinir - Google Patents

Crystalline forms of cefdinir

Info

Publication number
WO2006018807A8
WO2006018807A8 PCT/IB2005/052691 IB2005052691W WO2006018807A8 WO 2006018807 A8 WO2006018807 A8 WO 2006018807A8 IB 2005052691 W IB2005052691 W IB 2005052691W WO 2006018807 A8 WO2006018807 A8 WO 2006018807A8
Authority
WO
WIPO (PCT)
Prior art keywords
cefdinir
crystalline forms
relates
polymorphic forms
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/052691
Other languages
French (fr)
Other versions
WO2006018807A1 (en
Inventor
Manu Mahendru
Ram Chander Aryan
Satish Kumar
Bhargav Pandya
Sanjam Duggal
Sanjay Gade
Yatendra Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2006018807A1 publication Critical patent/WO2006018807A1/en
Publication of WO2006018807A8 publication Critical patent/WO2006018807A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to processes for the preparation of crystalline polymorphic forms of cefdinir of formula I. More particularly, it relates to the preparation of crystalline polymorphic forms of cefdinir designated as Forms B and C. The invention also relates to pharmaceutical compositions that include the polymorphic forms B and C, and the use of the compositions for treating bacterial infections.
PCT/IB2005/052691 2004-08-16 2005-08-15 Crystalline forms of cefdinir Ceased WO2006018807A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN1508DE2004 2004-08-16
IN1508/DEL/2004 2004-08-16
IN1646/DEL/2004 2004-08-31
IN1646DE2004 2004-08-31
IN434DE2005 2005-02-28
IN434/DEL/2005 2005-02-28

Publications (2)

Publication Number Publication Date
WO2006018807A1 WO2006018807A1 (en) 2006-02-23
WO2006018807A8 true WO2006018807A8 (en) 2006-08-10

Family

ID=35169921

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/052691 Ceased WO2006018807A1 (en) 2004-08-16 2005-08-15 Crystalline forms of cefdinir

Country Status (1)

Country Link
WO (1) WO2006018807A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016623A1 (en) 2002-08-13 2004-02-26 Sandoz Ag A cefdinir intermediate
WO2006059753A1 (en) 2004-11-30 2006-06-08 Astellas Pharma Inc. Novel oral pharmaceutical suspension of cefdinir crystal
JP2008525531A (en) * 2005-10-31 2008-07-17 テバ ファーマシューティカル インダストリーズ リミティド Crystalline form of cefdinir potassium salt
JP2008524265A (en) * 2005-10-31 2008-07-10 テバ ファーマシューティカル インダストリーズ リミティド Method for producing cefdinir
CN103497204B (en) * 2013-10-10 2016-03-23 珠海金鸿药业股份有限公司 A kind of Cefdinir compound, its dispersible tablet and preparation method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA885709B (en) * 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
ES2175167T3 (en) * 1995-12-27 2002-11-16 Hanmi Pharmaceutical Co Ltd PROCEDURE FOR THE PREPARATION OF CEFDINIR.
AT405283B (en) * 1997-04-04 1999-06-25 Biochemie Gmbh NEW CRYSTALLINE 7- (Z) - (2- (2-AMINOTHIAZOL-4-YL) -2-HYDROXYIMINOACETAMIDO) -3-VINYL-3-CEPHEM-4- CARBONIC ACID DICYCLOHEXYLAMMONIUM SALTS AND METHODS FOR THE PRODUCTION THEREOF
ITMI20020913A0 (en) * 2002-04-29 2002-04-29 Acs Dobfar Spa NEW CRYSTALLINE FORM OF CEFDINIR
WO2004016623A1 (en) * 2002-08-13 2004-02-26 Sandoz Ag A cefdinir intermediate
ITMI20022724A1 (en) * 2002-12-20 2004-06-21 Antibioticos Spa CRYSTALLINE SALTS OF CEFDINIR.
US20070106073A1 (en) * 2003-03-24 2007-05-10 Eiji Imai Novel crystal of 7-[2-[(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
WO2005090360A1 (en) * 2004-03-19 2005-09-29 Orchid Chemicals & Pharmaceuticals Limited Novel polymorph of cefdinir

Also Published As

Publication number Publication date
WO2006018807A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
WO2004082822A3 (en) Methods for isolating crystalline form i of 5-azacytidine
WO2008013838A3 (en) Pyridizinone derivatives
WO2006011050A3 (en) Pyridine derivatives
WO2004074244A3 (en) Pyrimidine compounds
WO2006092213A8 (en) Pyrazolylcarboxanilides
MXPA05012025A (en) Imidazo and thiazolopyridines as jak3 kinase inhibitors.
WO2004082619A3 (en) Forms of 5-azacytidine
MX2007005221A (en) Ascomycin crystalline forms and preparation thereof.
WO2008115281A3 (en) Compounds for treating viral infections
WO2007021937A3 (en) Unsaturated heterocyclic derivatives
WO2008073332A3 (en) Creatine compositions for skin treatment
TW200420541A (en) Crystalline forms
WO2007052023A3 (en) Novel compounds
WO2008088779A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2007109799A3 (en) Polymorphs of eszopiclone malate
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2007044950A3 (en) Crystalline forms of docetaxel and processes for their preparation
WO2004106322A3 (en) Polymorphs of aripiprazole
WO2007098273A3 (en) Novel crystalline forms of armodafinil and preparation thereof
WO2006003492A3 (en) Compositions and methods for treating pathological infections
WO2007066336A3 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
WO2006120563A3 (en) Antibacterial agents
WO2005055943A3 (en) Vinorelbine derivatives
WO2008038092A3 (en) Substituted piperidinophenyl oxazolidinones
WO2008033935A3 (en) Vinorelbine derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase